Barriers to Cure for Children with Cancer in India and Strategies to Improve Outcomes: A Report by the Indian Pediatric Hematology Oncology Group

被引:15
|
作者
Yadav, Satya Prakash [1 ]
Rastogi, Neha [2 ]
Kharya, Gaurav [3 ]
Misra, Ruchira [4 ]
Ramzan, Mohammed [1 ]
Katewa, Satyendra [5 ]
Dua, Vikas [6 ]
Bhat, Sunil [7 ,8 ]
Kellie, Stewart J. [9 ,10 ]
Howard, Scott C. [11 ]
机构
[1] Fortis Mem Res Inst, Pediat Hematol & Bone Marrow Transplant Unit, Gurgaon 122002, Haryana, India
[2] BJ Wadia Hosp Children, Dept Pediat Hematol Oncol, Bombay, Maharashtra, India
[3] Royal Victoria Infirm, Great North Children Hosp, Pediat Oncol Unit, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
[4] Medanta Hosp, Pediat Oncol Unit, Gurgaon, India
[5] Hosp Sick Children, Dept Pediat Hematol Oncol, Toronto, ON M5G 1X8, Canada
[6] Natl Univ Singapore Hosp, Dept Pediat Oncol, Singapore 117548, Singapore
[7] Narayana Hlth Multispecialty Hosp, Pediat Hematol Oncol & BMT Unit, Bangalore, Karnataka, India
[8] Mazumdar Shaw Canc Ctr, Bangalore, Karnataka, India
[9] Childrens Hosp Westmead, Oncol Unit, Sydney, NSW, Australia
[10] Univ Sydney, Sydney, NSW 2006, Australia
[11] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA
关键词
barriers; childhood cancer; India; outcome; ACUTE LYMPHOBLASTIC-LEUKEMIA; CHILDHOOD-CANCER; TREATMENT ABANDONMENT; LOW-INCOME; SURVIVAL; COUNTRIES; REFUSAL; SEPSIS;
D O I
10.3109/08880018.2014.893596
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The survival of children with cancer in India is inferior to that of children in high-income countries. The Indian Pediatric Hematology Oncology Group (IPHOG) held a series of online meetings via www.Cure4kids.org to identify barriers to cure and develop strategies to improve outcomes. Five major hurdles were identified: delayed diagnosis, abandonment, sepsis, lack of co-operative groups, and relapse. Development of regional networks like IPHOG has allowed rapid identification of local causes of treatment failure for children with cancer in India and identification of strategies likely to improve care and outcomes in the participating centers. Next steps will include interventions to raise community awareness of childhood cancer, promote early diagnosis and referral, and reduce abandonment and toxic death at each center. Starting of fellowship programs in pediatric hemato-oncology, short training programs for pediatricians, publishing outcome data, formation of parent and patient support groups, choosing the right and effective treatment protocol, and setting up of bone marrow transplant services are some of the effective steps taken in the last decade, which needs to be supported further.
引用
收藏
页码:217 / 224
页数:8
相关论文
共 50 条
  • [31] Immunization of Children with Cancer in India Treated with Chemotherapy — Consensus Guideline from the Pediatric Hematology-Oncology Chapter and the Advisory Committee on Vaccination and Immunization Practices of the Indian Academy of Pediatrics
    Nirmalya Roy Moulik
    Piali Mandal
    Jagdish Chandra
    Shweta Bansal
    Pramod Jog
    S. Sanjay
    Nitin Shah
    Ramandeep Singh Arora
    Indian Pediatrics, 2019, 56 : 1041 - 1048
  • [32] Outcomes for B-precursor patients in legacy Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) studies in childhood Acute Lymphoblastic Leukemia (ALL): A Children's Oncology Group (COG) report
    Gaynon, Paul S.
    Camitta, Bruce C.
    Matloub, Yousif
    Martin, Paul L.
    Winick, Naomi
    Seibel, Nita L.
    Bowman, W. Paul
    Sather, Harland N.
    Devidas, Meenakshi
    Hunger, Stephen
    Carroll, William L.
    BLOOD, 2007, 110 (11) : 260A - 260A
  • [33] Characteristics and outcomes of second cancers in patients with childhood cancer: A report from the Taiwan Pediatric Oncology Group
    Ho, Wan-Ling
    Hung, Giun-Yi
    Yen, Hsiu-Ju
    Yang, Yung-Li
    Chang, Hsiu-Hao
    Lu, Meng-Yao
    Lin, Kai-Hsin
    Chen, Jiann-Shiuh
    Cheng, Chao-Neng
    Hung, Iou-Jih
    Yang, Chao-Ping
    Chen, Shih-Hsiang
    Liu, Hsi-Che
    Yeh, Ting-Chi
    Hou, Jen-Yin
    Hsiao, Chih-Cheng
    Sheen, Jiunn-Ming
    Chang, Tai-Tsung
    Wong, Tai-Tong
    Miser, James S.
    Liu, Yen-Lin
    Chen, Rong-Long
    Chen, Bow-Wen
    Peng, Ching-Tien
    Chang, Te-Kau
    Wu, Kang-Hsi
    Chang, Yu-Hsiang
    Wang, Jinn-Li
    Wang, Shih-Chung
    Lin, Ming-Tsan
    Hu, Fu-Chang
    Jou, Shiann-Tarng
    Lin, Dong-Tsamn
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 (01) : 350 - 359
  • [34] Recent Advances in the Management of Pediatric Acute Myeloid Leukemia-Report of the Hungarian Pediatric Oncology-Hematology Group
    Gaal, Zsuzsanna
    Jakab, Zsuzsanna
    Karai, Bettina
    Ujfalusi, Aniko
    Petras, Miklos
    Kallay, Krisztian
    Kelemen, Agnes
    Simon, Reka
    Krivan, Gergely
    Kovacs, Gabor T.
    Kiss, Csongor
    Szegedi, Istvan
    CANCERS, 2021, 13 (20)
  • [35] TURKISH NATIONAL PEDIATRIC CANCER REGISTRY 2002-2008 (TURKISH PEDIATRIC ONCOLOGY GROUP AND TURKISH PEDIATRIC HEMATOLOGY SOCIETY)
    Kutluk, Tezer
    Yesilipek, M. Akif
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 851 - 851
  • [36] Association of pregnancy history and birth characteristics with neuroblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group
    Hamrick, SEG
    Olshan, AF
    Neglia, JP
    Pollock, BH
    PAEDIATRIC AND PERINATAL EPIDEMIOLOGY, 2001, 15 (04) : 328 - 337
  • [37] Hormone and fertility drug use and the risk of neuroblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group
    Olshan, AF
    Smith, J
    Cook, MN
    Grufferman, S
    Pollock, BH
    Stram, DO
    Seeger, RC
    Look, AT
    Cohn, SL
    Castleberry, RP
    Bondy, ML
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1999, 150 (09) : 930 - 938
  • [38] Turkish National Pediatric Cancer Registry 2002-2008 (Turkish Pediatric Oncology Group and Turkish Pediatric Hematology Society)
    Kutluk, M. Tezer
    Yesilipek, Akif
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [39] Outcomes in CCG-2961, a Children's Oncology Group Phase 3 Trial for untreated pediatric acute myeloid leukemia: a report from the Children's Oncology Group
    Lange, Beverly J.
    Smith, Franklin O.
    Feusner, James
    Barnard, Dorothy R.
    Dinndorf, Patricia
    Feig, Stephen
    Heerema, Nyla A.
    Arndt, Carola
    Arceci, Robert J.
    Seibel, Nita
    Weiman, Margie
    Dusenbery, Kathryn
    Shannon, Kevin
    Luna-Fineman, Sandra
    Gerbing, Robert B.
    Alonzo, Todd A.
    BLOOD, 2008, 111 (03) : 1044 - 1053
  • [40] Pharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children’s oncology group
    Patrick A. Thompson
    Manish Gupta
    Gary L. Rosner
    Alexander Yu
    Jeffrey Barrett
    Lisa Bomgaars
    Mark L. Bernstein
    Susan M. Blaney
    John Mondick
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 1027 - 1037